Biomed Valley Discoveries Inc is a clinical-stage biotechnology company based in Kansas City, Missouri. Guided by their founders' intent of hope for life, they focus on translational and clinical efforts in areas of significant unmet need, with a unique funding model that promotes scientific innovation and breakthrough medicines.
With a risk-tolerant candidate sourcing approach, deep scientific interrogation, and an extensive collaborator network, Biomed Valley Discoveries aims to address unmet medical needs in cancer and other serious conditions. Their programs include the development of a highly selective inhibitor, therapeutic antibodies, and a promising bacteria-based treatment for tumors.
Generated from the website